Olatec Therapeutics
Jeanette Rooney, CPA, CGMA, has extensive experience in finance and accounting roles with companies like Olatec Therapeutics, Sharp, Vaco, Amneal Pharmaceuticals, VaxInnate Corporation, Merck & Co., Inc., and Johnson & Johnson. With a Bachelor of Science degree in Accounting from Rutgers Business School, Jeanette has demonstrated expertise in financial reporting, budget management, SEC filings, and strategic decision-making. Jeanette's background includes roles such as Vice President Finance & Treasurer, Finance Controller, and Financial Controller in the life sciences industry.
Olatec Therapeutics
Olatec is a privately held biopharmaceutical company developing a platform of safe, oral NLRP3 antagonist therapeutics, to treat and prevent a broad spectrum of acute and chronic inflammatory diseases that are known to be mediated by Interleukin-1 (IL-1), including: arthritis, heart failure, asthma, Alzheimer’s disease, multiple sclerosis, type-2 diabetes, melanoma and breast cancers, among others.